Abstract
Purified C3a, a cleavage product of the third component of complement,was incubated with various cell types of human and mouse origin. All the tumour cell types tested were lysed by low concentrations of C3a, whereas normal human lymphocytes were relatively resistant. No lysis was produced by C3 or C3b. The possible role of C3a in immunity against tumours is discussed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Ferluga, J., Schorlemmer, H., Baptista, L. et al. Cytolytic effects of the complement cleavage product, C3a. Br J Cancer 34, 626–634 (1976). https://doi.org/10.1038/bjc.1976.223
Issue Date:
DOI: https://doi.org/10.1038/bjc.1976.223